India Stem Cell Market to Grow with a CAGR of 12.15% through 2030
Increasing Prevalence of Chronic Diseases and Genetic Disorders and Expansion of Stem Cell Banking Services are expected to drive the India Stem Cell Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “India Stem Cell Market - By Region, Competition, Forecast & Opportunities, 2030F”, the India Stem
Cell Market stood at USD 395.15 Million in 2024 and is anticipated to grow with a CAGR of 12.15%
in the forecast period, 2026-2030.
The Indian stem cell market is experiencing robust growth, driven by several key factors that underscore its potential in transforming healthcare in the country. The increasing prevalence of chronic diseases and genetic disorders is fueling demand for advanced treatments, with stem cell therapies emerging as a viable solution. The expanding geriatric population in India, which is more susceptible to conditions where stem cell therapies can be effective, further contributes to this growing need.
Significant advancements in biotechnology, combined with supportive government policies, have played a crucial role in propelling the market. Government initiatives, including funding from institutions such as the Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR), have fostered a conducive environment for stem cell research. Furthermore, the joint release of guidelines by the DBT and ICMR has provided much-needed clarity and incentives for further studies, accelerating progress in the sector.
The increasing public awareness and acceptance of stem cell therapies, driven by successful treatment outcomes, also acts as a catalyst for growth. These factors have combined to position India as one of the top 10 countries globally in stem cell research, with the market currently valued at approximately $1 billion. Experts forecast a compound annual growth rate (CAGR) of around 28% in the coming years, highlighting the sector’s promising trajectory.
India’s stem cell market is being shaped by several critical developments, one of the most notable being the rise of stem cell banks. These facilities, which collect, process, test, and preserve stem cells predominantly from umbilical cords have revolutionized the accessibility and adoption of stem cell therapies across the country. The growing number of stem cell banks reflects the increasing acceptance of these therapies among the Indian population.
Despite the optimism surrounding the sector, challenges remain. Ethical concerns, particularly regarding embryonic stem cell research, have resulted in stringent regulatory frameworks, which can sometimes hinder progress. Additionally, the high cost of stem cell therapies continues to be a barrier for many, limiting access to these treatments for a significant portion of the population.
Looking ahead, the future of India’s stem cell market remains promising, with emerging trends poised to drive further growth. The development of induced pluripotent stem cells (iPSCs) offers tremendous potential for new therapeutic applications, while advancements in gene-editing technologies like CRISPR-Cas9 are set to revolutionize the field. As research continues to evolve, the market’s expansion will depend heavily on translating these breakthroughs into accessible and effective therapeutic solutions that can improve patient outcomes and enhance quality of life for millions in India.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "India Stem Cell Market”
The India Stem
Cell Market is segmented into product, application, technology, therapy, end user, regional
distribution, and company.
Based on technology,
in the landscape of India's stem cell technology market, the sector of Cell
Acquisition is expected to dominate due to its critical role in the initial
phase of stem cell therapy. This dominance can be attributed to the efficiency
and effectiveness of cell acquisition, which directly impacts the success rate
of subsequent procedures. Cell acquisition involves the collection of stem
cells from various sources such as bone marrow, umbilical cord blood, and
peripheral blood. The advancements in technology continually enhance the
methods and tools for stem cell acquisition, further solidifying its pivotal
position in the market. As research progresses and new techniques emerge, the
field of cell acquisition is poised to witness even more significant growth and
innovation. The continuous exploration of novel sources and techniques for
acquiring stem cells will contribute to the expansion of the market,
facilitating the development of more advanced and accessible stem cell
therapies.
Major companies
operating in India Stem Cell Market are:
- Thermo Fisher Scientific India Pvt. Ltd.
- Pluristem Therapeutics Inc.
- Becton Dickinson Private Limited
- Stem Cell Care India
- Merck Life Science Pvt. Ltd.
- Cordlife Sciences India Pvt. Ltd
- Lifecell International Pvt.Ltd
- Stemcyte India Therapeutics Pvt. Ltd.
- Stempeutics Research Pvt. Ltd.
- ReeLabs Pvt. Ltd.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The unwavering
support from the Indian government for stem cell research has been instrumental
in fostering the growth of this market. The government's commitment to funding
research initiatives and creating a favorable regulatory environment has
attracted both domestic and international stakeholders to invest in the Indian
stem cell industry. This support has not only accelerated the pace of research
and development but has also facilitated the translation of scientific
discoveries into clinical applications. India's robust healthcare
infrastructure and significant investments in research and development have
positioned the country at the forefront of stem cell innovation. The presence
of world-class hospitals, research institutions, and biotechnology companies,
coupled with a talented pool of scientists and clinicians, has created a
fertile ground for groundbreaking discoveries and transformative treatments.
India's vibrant ecosystem, characterized by collaboration and knowledge
exchange, is poised to revolutionize the field of stem cell research and
therapeutic applications.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.
“India Stem Cell Market, By Product (Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), By Therapy (Autologous, Allogeneic), By End User (Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes), By Region, Competition, Forecast & Opportunities, 2020-2030F”,
has evaluated the future growth potential of India Stem Cell Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India Stem Cell Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com